These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
3. [Peripheral T-cell lymphoma: diagnosis and treatment]. Reimer P; Hentrich M Dtsch Med Wochenschr; 2006 Mar; 131(13):685-90. PubMed ID: 16555177 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience. Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054 [TBL] [Abstract][Full Text] [Related]
5. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen]. Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720 [TBL] [Abstract][Full Text] [Related]
6. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
7. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen]. Huang HQ; Peng YL; Lin XB; Sun XF; Lin TY; Xia ZJ; Li YH; Cai QQ; He YJ; Jiang WQ; Guan ZZ Ai Zheng; 2004 Nov; 23(11 Suppl):1443-7. PubMed ID: 15566653 [TBL] [Abstract][Full Text] [Related]
9. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259 [TBL] [Abstract][Full Text] [Related]
10. [Recent progress in the treatment of malignant lymphoma]. Tobinai K; Shimoyama M Gan To Kagaku Ryoho; 1994 Jul; 21(8):1151-6. PubMed ID: 8031155 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of primary mediastinal large B-cell lymphomas]. Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753 [TBL] [Abstract][Full Text] [Related]
12. Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell. Liang R; Todd D; Ho FC Hematol Oncol; 1996 Mar; 14(1):1-6. PubMed ID: 8613131 [TBL] [Abstract][Full Text] [Related]
13. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides. Horwitz SM; Duvic M; Hsi ED Clin Adv Hematol Oncol; 2010 Dec; 8(12):1-15. PubMed ID: 21344783 [TBL] [Abstract][Full Text] [Related]
14. New drug therapies in peripheral T-cell lymphoma. Howman RA; Prince HM Expert Rev Anticancer Ther; 2011 Mar; 11(3):457-72. PubMed ID: 21417858 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a primary gastric T-cell lymphoma lacking the human T-cell leukemia virus type 1. Yachida S; Sasako M; Tobinai K; Matsuno Y; Shimoda T Hepatogastroenterology; 2010; 57(98):383-7. PubMed ID: 20583449 [TBL] [Abstract][Full Text] [Related]
16. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082 [TBL] [Abstract][Full Text] [Related]
17. Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. Simon A; Peoch M; Casassus P; Deconinck E; Colombat P; Desablens B; Tournilhac O; Eghbali H; Foussard C; Jaubert J; Vilque JP; Rossi JF; Lucas V; Delwail V; Thyss A; Maloisel F; Milpied N; le Gouill S; Lamy T; Gressin R Br J Haematol; 2010 Oct; 151(2):159-66. PubMed ID: 20738307 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases]. Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799 [TBL] [Abstract][Full Text] [Related]
19. Current treatment of peripheral T-cell lymphoma. Horwitz SM; Coiffier B; Hsi ED; Pro B Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915 [TBL] [Abstract][Full Text] [Related]
20. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas. Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]